Arkolith/Insider Trading/DYN/Form 4

Kersten Dirk

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Jun 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.5M
Net Open-Market Flow
-$5.5M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 23, 2026Sell(S)72K$21.04$1.5M3.8M
Jun 23, 2026Sell(S)2K$21.47$36K3.8M
Jun 22, 2026Sell(S)191K$20.57$3.9M3.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-281119) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML